Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): The Renal Research Institute (RRI)-CKD Study

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2891-2898

  Dellegrottaglie, Santo ^a,b   Sands, Robin L ^c   Gillespie, Brenda W ^c   Gnanasekaran, Gowrishankar ^d   Zannad, Faiez ^e   Sengstock, David ^f   Finkelstein, Frederic ^g   Kiser, Margaret ^h   Eisele, George ⁱ   Hinderliter, Alan L ^h   Levin, Nathan W ^j   Cattan, Valerie ^e   Saran, Rajiv ^c,k   Rajagopalan, Sanjay ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Z/M A Wiener Cardiovasc Inst   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f Oakwood Healthcare Inc   (United States)

^g HOSPITAL OF SAINT RAPHAEL   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ ALBANY MEDICAL CENTER   (United States)

^j RENAL RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

kidney disease; vascular function; ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBOXY TERMINAL TELOPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; ARTERIAL STIFFNESS; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RACE;

ACADEMIES AND INSTITUTES; ARTERIES; BIOLOGICAL MARKERS; COHORT STUDIES; COLLAGEN; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROGNOSIS; PROSPECTIVE STUDIES; VASCULAR STIFFNESS;

EID: 80053195337     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr186     Document Type: Article

References (45)

1. Levin A, Singer J, Thompson CR et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-354 (Pubitemid 26075843)
2. Paoletti E, Bellino D, Cassottana P et al. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 2005; 46: 320-327 (Pubitemid 41040362)
3. Bouthier JD, De Luca N, Safar ME et al. Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J 1985; 109: 1345-1352 (Pubitemid 16119655)
4. Blacher J, Safar ME, Guerin AP et al. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003; 63: 1852-1860 (Pubitemid 36513333)
5. Matsumoto Y, Hamada M, Hiwada K. Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology 2000; 51: 933-941
6. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35 (4 Suppl 1): S117-S131 (Pubitemid 30183825)
7. Bishop JE, Laurent GJ. Collagen turnover and its regulation in the normal and hypertrophying heart. Eur Heart J 1995; 16 (Suppl C): 38-44
8. Gonzalez A, Lopez B, Querejeta R et al. Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? J Mol Cell Cardiol 2002; 34: 1585-1593 (Pubitemid 35454474)
9. Bozkaya YT, Aydin HH, Celik HA et al. Increased myocardial collagen turnover in patients with progressive cardiac conduction disease. Pacing Clin Electrophysiol 2008; 31: 1284-1290
10. Diez J, Laviades C, Mayor G et al. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91: 1450-1456
11. Uusimaa P, Risteli J, Niemela M et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 1997; 96: 2565-2572 (Pubitemid 27451347)
12. Zannad F, Alla F, Dousset B et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 2000; 102: 2700-2706
13. Chatzikyriakou SV, Tziakas DN, Chalikias GK et al. Serum levels of collagen type-I degradation markers are associated with vascular stiffness in chronic heart failure patients. Eur J Heart Fail 2008; 10: 1181-1185
14. Lombardi R, Betocchi S, Losi MA et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 2003; 108: 1455-1460 (Pubitemid 37176451)
15. Perlman RL, Kiser M, Finkelstein F et al. The longitudinal chronic kidney disease study: a prospective cohort study of predialysis renal failure. Semin Dial 2003; 16: 418-423 (Pubitemid 37550118)
16. Schiller NB, Maurer G, Ritter SB et al. Transesophageal echocardiography. J Am Soc Echo 1989; 2: 354-357
17. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458 (Pubitemid 16119719)
18. Sengstock D, Vaitkevicius PV, Supiano MA. Does increased arterial stiffness increase the risk for postural hypotension? Am J Geriatr Cardiol 2005; 14: 224-229
19. Sengstock DM, Vaitkevicius PV, Supiano MA. Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults. J Clin Endocrinol Metab 2005; 90: 2823-2827 (Pubitemid 40686330)
20. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl 1996; 14: S147-S157 (Pubitemid 27051090)
21. Myers RH. Classical and Modern Regression with Applications. Boston: Duxbury Press, 1986
22. Shimizu M, Umeda K, Sugihara N et al. Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 1993; 46: 32-36 (Pubitemid 23039583)
23. Brilla CG, Maisch B, Weber KT. Myocardial collagen matrix remodelling in arterial hypertension. Eur Heart J 1992; 13 (Suppl D): 24-32
24. Weber KT, Brilla CG, Campbell SE. Regulatory mechanisms of myocardial hypertrophy and fibrosis: results of in vivo studies. Cardiology 1992; 81: 266-273 (Pubitemid 23113881)
25. Tanaka M, Fujiwara H, Onodera T et al. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986; 55: 575-581 (Pubitemid 16092908)
26. Dingemans KP, Teeling P, Lagendijk JH et al. Extracellular matrix of the human aortic media: an ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Rec 2000; 258: 1-14 (Pubitemid 30030450)
27. Fatema K, Hirono O, Masakane I et al. Dynamic assessment of myocardial involvement in patients with end-stage renal disease by ultrasonic tissue characterization and serum markers of collagen metabolism. Clin Cardiol 2004; 27: 228-234 (Pubitemid 38451160)
28. Querejeta R, Lopez B, Gonzalez A et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 2004; 110: 1263-1268 (Pubitemid 39202343)
29. Sasaguri M, Noda K, Tashiro E et al. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients. Hypertens Res 2000; 23: 317-322 (Pubitemid 30444992)
30. Davies J, Gavin A, Band M et al. Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. Br J Clin Pharmacol 2005; 59: 520-523 (Pubitemid 40632241)
31. Skalska A, Gasowski J, Cwynar M et al. The relationship between pulse wave velocity and indexes of collagen synthesis in hypertensive patients, according to the level of systolic blood pressure. J Hum Hypertens 2005; 19: 731-735 (Pubitemid 43118097)
32. London GM. [Arteriosclerosis and arterial calcifications in chronic kidney insufficiency]. Nephrol Ther 2005; 1 (Suppl 4): S351-S354 (Pubitemid 43028042)
33. IntenganHD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38: 581-587
34. Henry RM, Kamp O, Kostense PJ et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon-the Hoorn Study. Kidney Int 2005; 68: 673-679 (Pubitemid 43323122)
35. Sengstock DM, Sands RL, Gillespie BW et al. Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease. Nephrol Dial Transplant 2010; 25: 853-861
36. Saba PS, Roman MJ, Pini R et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22: 1873-1880 (Pubitemid 23359646)
37. London GM. [Arterial stiffness, wave reflections and myocardial protection: the REASON project]. Drugs 2003; 63 (Spec No 1): 9-17. (Pubitemid 36384614)
38. Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med 1996; 156: 146-157 (Pubitemid 26024749)
39. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J 2004; 25: 1776-1787 (Pubitemid 39330228)
40. Amann K, Tornig J, Kugel B et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 2003; 63: 1296-1301 (Pubitemid 36349995)
41. Neves KR, Graciolli FG, dos Reis LM et al. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 2004; 66: 2237-2244 (Pubitemid 41115286)
42. Rodriguez-Ayala E, Avila-Diaz M, Foyo-Niembro E et al. Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone. Nephron Physiol 2006; 103: 112-118
43. Zoccali C, Benedetto FA, Mallamaci F et al. Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients. J Hypertens 2001; 19: 287-293 (Pubitemid 32116280)
44. Kotzmann H, Riedl M, Pietschmann P et al. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis. J Nephrol 2004; 17: 87-94 (Pubitemid 38444633)
45. Mesquita M, Wittersheim E, Demulder A et al. Bone cytokines and renal osteodystrophy in peritoneal dialysis patients. Adv Perit Dial 2005; 21: 181-184